YPB Group (ASX:YPB) - Executive Chairman, John Houston
Executive Chairman, John Houston
Source: The Market Herald
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Anti-counterfeit and consumer solutions provider YPB Group (YPB) secures its first paid commercial trial of MotifMicro1 (MM1) with OpalANZ
  • OpalANZ is one of Australia and New Zealand’s leading packaging and paper manufacturing groups, exporting to more than 70 countries
  • The trial will test the performance of MotifMicro1 in multiple different coatings across Opal’s product range to identify the highest value application
  • MotifMicro1 is YPB’s smartphone-readable anti-counterfeit technology that reads authentication marks on both flat and curved surfaced
  • Shares in YPB are up a healthy 50 per cent on the market and are trading at 0.3 cents at 12:31 pm AEST

Anti-counterfeit and consumer solutions provider YPB Group (YPB) has secured its first paid commercial trial of MotifMicro1 (MM1) with OpalANZ.

Previously owned by Orora (ORA), OpalANZ is one of Australia and New Zealand’s leading packaging and paper manufacturing groups.

It was sold to Nippon Paper Group in October 2019 and currently has more than 80 operating sites and exports to over 70 countries.

The trial will test the performance of MotifMicro1 in multiple coatings and substrates across Opal’s product range to identify the highest value applications for use.

A 12-month licence agreement will then be entered to give OpalANZ the exclusivity to distribute MotifMicro1 in the Australiasian recyclable, paper-based packaging market.

Upon completion of the 12 months, the agreement can be renewed for a three-year term.

MoritfMicro1 is YPB’s multi-patented, high security, smartphone-readable, anti-counterfeit technology which is invisible to the naked eye.

It can read authentication marks on both flat and curved surfaced, making it accessible to a wide range of products.

Executive Chairman John Houston is excited by the trial.

“I’m pleased and encouraged by the enthusiastic feedback from global and Australian partners for our proprietary MM1 product,” Mr Houston said.

“This first paid commercial trial is a major breakthrough for the company and the technology, particularly given the pedigrees of our new partner Opal and its parent Nippon Paper.”

YPB is continuing to progress trials with a range of other companies and will keep the market updated as it progresses.

Shares in YPB were up a healthy 50 per cent on the market and were trading at 0.3 cents at 12:31 pm AEST.

YPB by the numbers
More From The Market Online

Cettire turbulent on $191M revenue, but no word on customs scandal

Cettire shares spiked upwards right out the gate on Friday on the same day the company…

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms'…

23% profit jump for NZ dairy co-op Fonterra

New Zealand dairy cooperative Fonterra has raised its profits 23 percent to NZ$674 million in the…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…